Autonomix Medical, Inc. has been granted a new U.S. patent—U.S. Patent No. 12,295,646—for its innovative “Smart Torquer and Methods for Using the Same,” a critical advancement in the company’s mission to enhance precision and control in minimally invasive, nerve-targeted procedures. This smart torquer device is engineered to improve the manipulation of elongated intravascular instruments while integrating electronic systems for seamless mechanical control and data communication. The patent significantly strengthens Autonomix’s IP portfolio, which now includes over 80 issued patents, and supports its strategic focus on reshaping interventional care across high-need specialties such as cardiology, neurosurgery, and interventional radiology.

The smart torquer comprises a multi-functional mechanism that attaches securely to intravascular tools, enabling clinicians to deliver targeted torque while simultaneously transmitting signals and data. This integration is particularly beneficial in procedures where precision navigation and real-time feedback are essential, such as in nerve mapping, ablation, and complex vascular access. The device’s built-in communication module and electrical connection interface support interoperability with broader systems, positioning it as a key enabler for intelligent, connected surgical workflows. By combining tactile control with digital connectivity, Autonomix is addressing critical limitations in existing intravascular navigation tools and improving procedural accuracy.